Viewing Study NCT05826366


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2026-02-23 @ 8:08 PM
Study NCT ID: NCT05826366
Status: COMPLETED
Last Update Posted: 2025-06-03
First Post: 2023-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module